Optimum designs for clinical trials in personalized medicine when response variance depends on treatment
Belmiro P M Duarte1,2,3, Anthony C Atkinson4
1Polytechnic Institute of Coimbra, ISEC, Coimbra, Portugal.
Abstract:
We study optimal designs for clinical trials when the value of the response and its variance depend on treatment and covariates are included in the response model. Such designs are generalizations of Neyman allocation, commonly used in personalized medicine when external factors may have differing effects on the response depending on subgroups of patients. We develop theoretical results for D-, A-, E- and D-optimal designs and construct semidefinite programming (SDP) formulations that support their numerical computation. D-, A-, and E-optimal designs are appropriate for efficient estimation of distinct properties of the parameters of the response models. Our formulation allows finding optimal allocation schemes for a general number of treatments and of covariates. Finally, we study frequentist sequential clinical trial allocation within contexts where response parameters and their respective variances remain unknown. We illustrate, with a simulated example and with a redesigned clinical trial on the treatment of neuro-degenerative disease, that both theoretical and SDP results, derived under the assumption of known variances, converge asymptotically to allocations obtained through the sequential scheme. Procedures to use static and sequential allocation are proposed.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
Analysis of Population Pharmacokinetic Data
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Clinical Trials: Overview
Crossover Experiments
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Clinical Trials
There are four phases in a clinical trial. A phase one...
